XML 18 R52.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

REVENUE- Revenue by Region (Details) - USD ($) $ in Millions | 3 Months Ended
--- | ---
Jan. 31, 2020 | Jan. 31, 2019
Net revenue | $ 1,357 | $ 1,284
Life Sciences and Applied Markets |  |
Net revenue | 638 | 607
Diagnostics and Genomics |  |
Net revenue | 249 | 235
Agilent CrossLab |  |
Net revenue | 470 | 442
Americas |  |
Net revenue | 494 | 433
Americas | Life Sciences and Applied Markets |  |
Net revenue | 209 | 168
Americas | Diagnostics and Genomics |  |
Net revenue | 118 | 109
Americas | Agilent CrossLab |  |
Net revenue | 167 | 156
Europe |  |
Net revenue | 392 | 383
Europe | Life Sciences and Applied Markets |  |
Net revenue | 167 | 164
Europe | Diagnostics and Genomics |  |
Net revenue | 92 | 91
Europe | Agilent CrossLab |  |
Net revenue | 133 | 128
Asia Pacific |  |
Net revenue | 471 | 468
Asia Pacific | Life Sciences and Applied Markets |  |
Net revenue | 262 | 275
Asia Pacific | Diagnostics and Genomics |  |
Net revenue | 39 | 35
Asia Pacific | Agilent CrossLab |  |
Net revenue | $ 170 | $ 158

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AmericasMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AsiaPacificMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |